This journal article is a practice guideline that provides recommendations summarizing the growing literature and current best practices of chronic Hepatitis C Virus (HCV) treatment, including treatment in difficult-to-treat populations. These recommendations are based on an extensive review of published data, national consensus recommendations, and input from thought leaders involved in HCV care and treatment.
This poster is to be used as a pocket resource contains photographs and agents for treatment of oral manifestations of HIV disease including: antifungal, antiviral, topical, antibacterial, and other treatments.
This report describes approaches for managing patients with TB who are candidates for or who are undergoing protease inhibitor therapy and presents interim recommendations for managing these patients until additional data are available and formal guidelines are issued. Protease inhibitors interact with rifamycin derivatives, which are used to treat and prevent the mycobacterial infections commonly observed in patients with the HIV. The report provides background information on the management of TB and the three treatment options currently available for these patients.
